Nuveen’s Sanara MedTech SMTI Stock Holding History

Nuveen’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$261K	Buy	+15,207	New	+$313K	﹤0.01%	3032
2025 Q4	–	Sell	-20,752	Closed	-$658K	–	3294
2025 Q3	$658K	Buy	+20,752	New	+$626K	﹤0.01%	2804
2025 Q2	–	Sell	-10,565	Closed	-$326K	–	3397
2025 Q1	$326K	Buy	+10,565	New	+$359K	﹤0.01%	3015
2024 Q2	–	Sell	-5,537	Closed	-$205K	–	3410
2024 Q1	$205K	Buy	5,537 +448	+9%	+$16.7K	﹤0.01%	3180
2023 Q4	$209K	Buy	+5,089	New	+$163K	﹤0.01%	3208
2023 Q3	–	Sell	-5,089	Closed	-$204K	–	3237
2023 Q2	$204K	Buy	+5,089	New	+$208K	﹤0.01%	3094

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nuveen's SMTI Position: Q1 2026 in Review

Nuveen opened a new position in Sanara MedTech (SMTI) in Q1 2026: 15,207 shares worth $261K. The stake represents ﹤0.01% of the portfolio and ranks #3032 among its holdings. This is a return to the name: Nuveen previously reported a position in SMTI as recently as Q3 2025.

Nuveen first reported a position in SMTI in Q2 2023 and has held it in 6 quarters since. The position peaked at $658K in Q3 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Nuveen held 15,207 shares of Sanara MedTech worth $261K as of Q1 2026.
Sanara MedTech was a new Nuveen position in Q1 2026.
Sanara MedTech made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3032 holding.
Nuveen first reported a position in Sanara MedTech in Q2 2023 and has held it in 6 quarters since.
Nuveen's Sanara MedTech position peaked at $658K in Q3 2025.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.